Stock HBIO HARVARD BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Harvard Bioscience, Inc.

Equities

HBIO

US4169061052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
3.27 USD -2.39% Intraday chart for Harvard Bioscience, Inc. -3.54% -38.88%
May. 07 Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07 Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M MT

Evolution of the average Target Price on Harvard Bioscience, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a0481dd68fe74bfcd979b2eee9776879.HwvSl9EKVPI2OzMDn4hUpawbGOd4QNcJOBxpOltvXC8.aken9uZ8E4pAaURJ5uQi9-JpLJ0aArVIWmoOfzc6DHB-TYvPn3g7kE55eg~1d8e921d5a8bc8862c9312c96a1b2c5b

Analyst Recommendations on Harvard Bioscience, Inc.

Benchmark Adjusts Price Target on Harvard Bioscience to $7 From $4, Maintains Buy Rating MT
Keybanc Adjusts Price Target on Harvard Bioscience to $7 From $5, Maintains Overweight Rating MT
KeyBanc Capital Markets Trims Price Target on Harvard Bioscience to $5 From $7, Maintains Overweight Rating MT
KeyBanc Capital Markets Trims Price Target on Harvard Bioscience to $7 From $10, Keeps Overweight Rating MT
HARVARD BIOSCIENCE : Northland Capital Starts Harvard Bioscience at Outperform With $6 Price Target MT
HARVARD BIOSCIENCE : KeyBanc Initiates Harvard Bioscience at Overweight with $6 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.27 USD
Average target price
7 USD
Spread / Average Target
+114.07%
High Price Target
7 USD
Spread / Highest target
+114.07%
Low Price Target
7 USD
Spread / Lowest Target
+114.07%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Harvard Bioscience, Inc.

Benchmark Company
KeyBanc Capital Markets

Ratings for Harvard Bioscience, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HBIO Stock
  4. Consensus Harvard Bioscience, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW